BR0209064A - Hidroxamatos de alquila tricìclicos, sua preparaçãoe seu uso como inibidores de proliferação de células - Google Patents
Hidroxamatos de alquila tricìclicos, sua preparaçãoe seu uso como inibidores de proliferação de célulasInfo
- Publication number
- BR0209064A BR0209064A BR0209064-3A BR0209064A BR0209064A BR 0209064 A BR0209064 A BR 0209064A BR 0209064 A BR0209064 A BR 0209064A BR 0209064 A BR0209064 A BR 0209064A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- cell proliferation
- tricyclic alkyl
- proliferation inhibitors
- alkyl hydroxamates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/12—[b,e]-condensed
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
- Pyrane Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"HIDROXAMATOS DE ALQUILA TRICìCLICOS, SUA PREPARAçãO E SEU USO COMO INIBIDORES DE PROLIFERAçãO DE CéLULAS". A invenção refere-se a compostos de fórmula (I), em que R~ 1~, R~ 2~, A, X, Y e Z têm os significados definidos no relatório descritivo, método de fabricação destes compostos e compostos farmacêuticos com atividade inibidora de HDAC contendo um tal composto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01109428 | 2001-04-23 | ||
PCT/EP2002/004349 WO2002085883A1 (en) | 2001-04-23 | 2002-04-19 | Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0209064A true BR0209064A (pt) | 2004-08-10 |
Family
ID=8177162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0209064-3A BR0209064A (pt) | 2001-04-23 | 2002-04-19 | Hidroxamatos de alquila tricìclicos, sua preparaçãoe seu uso como inibidores de proliferação de células |
Country Status (16)
Country | Link |
---|---|
US (1) | US6512123B2 (pt) |
EP (1) | EP1385837B1 (pt) |
JP (1) | JP4142453B2 (pt) |
KR (1) | KR100591501B1 (pt) |
CN (1) | CN1310904C (pt) |
AR (1) | AR035455A1 (pt) |
AT (1) | ATE306480T1 (pt) |
AU (1) | AU2002254991B2 (pt) |
BR (1) | BR0209064A (pt) |
CA (1) | CA2442994A1 (pt) |
CR (1) | CR9430A (pt) |
DE (1) | DE60206616T2 (pt) |
ES (1) | ES2249572T3 (pt) |
MX (1) | MXPA03009132A (pt) |
WO (1) | WO2002085883A1 (pt) |
ZA (1) | ZA200307793B (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6777217B1 (en) * | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
US6822267B1 (en) * | 1997-08-20 | 2004-11-23 | Advantest Corporation | Signal transmission circuit, CMOS semiconductor device, and circuit board |
US20030129724A1 (en) | 2000-03-03 | 2003-07-10 | Grozinger Christina M. | Class II human histone deacetylases, and uses related thereto |
US7244853B2 (en) | 2001-05-09 | 2007-07-17 | President And Fellows Of Harvard College | Dioxanes and uses thereof |
US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
WO2004067480A2 (en) * | 2003-01-25 | 2004-08-12 | Oxford Glycosciences (Uk) Ltd | Substituted phenylurea derivatives as hdac inhibitors |
EP1608628A2 (en) | 2003-03-17 | 2005-12-28 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
PL2238982T3 (pl) | 2003-06-27 | 2013-03-29 | Astellas Pharma Inc | Środek do terapii mięsaka tkanek miękkich |
WO2005058298A2 (en) * | 2003-12-10 | 2005-06-30 | Wisconsin Alumni Research Foundation | Fk228 analogs and their use as hdac-inhibitors |
WO2005065681A1 (en) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer |
WO2005066151A2 (en) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US20060128660A1 (en) * | 2004-12-10 | 2006-06-15 | Wisconsin Alumni Research Foundation | FK228 analogs and methods of making and using the same |
WO2006066133A2 (en) * | 2004-12-16 | 2006-06-22 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
IT1362675B (it) * | 2005-03-15 | 2009-06-25 | Menarini Internat Operations Luxembourg Sa | N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche |
EP2491926B1 (en) | 2005-03-22 | 2018-05-09 | President and Fellows of Harvard College | Treatment of protein degradation disorders |
US7642253B2 (en) * | 2005-05-11 | 2010-01-05 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
CA2606598C (en) * | 2005-05-13 | 2014-12-23 | Topotarget Uk Limited | Pharmaceutical formulations of hdac inhibitors |
JP2009501236A (ja) * | 2005-07-14 | 2009-01-15 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
WO2007077111A1 (en) * | 2005-12-30 | 2007-07-12 | F. Hoffmann-La Roche Ag | Compounds and methods for carbazole synthesis |
WO2007084390A2 (en) * | 2006-01-13 | 2007-07-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
AU2007345292B2 (en) | 2006-02-14 | 2013-10-31 | Dana-Farber Cancer Institute, Inc. | Bifunctional histone deacetylase inhibitors |
AU2007214458C1 (en) | 2006-02-14 | 2012-12-06 | Dana-Farber Cancer Institute, Inc. | Histone deacetylase inhibitors |
US8304451B2 (en) * | 2006-05-03 | 2012-11-06 | President And Fellows Of Harvard College | Histone deacetylase and tubulin deacetylase inhibitors |
ES2288803B1 (es) * | 2006-07-07 | 2008-12-16 | Universidad De Granada | Derivados de benzo(d)isotiazoles como inhibidores de las histonas desacetilasas. |
US8399452B2 (en) * | 2006-10-28 | 2013-03-19 | Methylgene Inc. | Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors |
AU2013205135B2 (en) * | 2006-10-28 | 2015-11-05 | Forum Pharmaceuticals Inc. | Inhibitors of histone deacetylase |
US8440716B2 (en) | 2008-07-23 | 2013-05-14 | President And Fellows Of Harvard College | Deacetylase inhibitors and uses thereof |
JP2012051804A (ja) * | 2008-12-26 | 2012-03-15 | Kyoto Univ | Eg5阻害剤 |
US8716344B2 (en) | 2009-08-11 | 2014-05-06 | President And Fellows Of Harvard College | Class- and isoform-specific HDAC inhibitors and uses thereof |
WO2015115410A1 (ja) * | 2014-01-28 | 2015-08-06 | 株式会社日本触媒 | 水素化反応方法 |
WO2017030892A1 (en) | 2015-08-14 | 2017-02-23 | Reaction Biology Corp. | Histone deacetylase inhibitors and methods for use thereof |
WO2023020416A1 (zh) * | 2021-08-16 | 2023-02-23 | 勤浩医药(苏州)有限公司 | 三环化合物、包含其的药物组合物及其用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2208893A1 (de) | 1972-02-25 | 1973-08-30 | Boehringer Mannheim Gmbh | Tricyclische alpha-oxy-carbonsaeurederivate und verfahren zur herstellung derselben |
US5369108A (en) * | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
ZA938897B (en) * | 1992-12-01 | 1994-08-01 | Smithkline Beecham Corp | Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds |
KR20000068414A (ko) * | 1996-09-04 | 2000-11-25 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 매트릭스 메탈로프로테이나제 억제제 및 그의 치료적 용도 |
AUPO721997A0 (en) * | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
EP1215203B1 (en) * | 1999-09-24 | 2005-02-16 | Ono Pharmaceutical Co., Ltd. | Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
-
2002
- 2002-04-08 AR ARP020101282A patent/AR035455A1/es not_active Application Discontinuation
- 2002-04-19 MX MXPA03009132A patent/MXPA03009132A/es active IP Right Grant
- 2002-04-19 KR KR1020037013744A patent/KR100591501B1/ko not_active IP Right Cessation
- 2002-04-19 AU AU2002254991A patent/AU2002254991B2/en not_active Ceased
- 2002-04-19 BR BR0209064-3A patent/BR0209064A/pt not_active IP Right Cessation
- 2002-04-19 JP JP2002583410A patent/JP4142453B2/ja not_active Expired - Fee Related
- 2002-04-19 EP EP02724292A patent/EP1385837B1/en not_active Expired - Lifetime
- 2002-04-19 DE DE60206616T patent/DE60206616T2/de not_active Expired - Fee Related
- 2002-04-19 AT AT02724292T patent/ATE306480T1/de not_active IP Right Cessation
- 2002-04-19 CN CNB028086546A patent/CN1310904C/zh not_active Expired - Fee Related
- 2002-04-19 ES ES02724292T patent/ES2249572T3/es not_active Expired - Lifetime
- 2002-04-19 CA CA002442994A patent/CA2442994A1/en not_active Abandoned
- 2002-04-19 WO PCT/EP2002/004349 patent/WO2002085883A1/en active IP Right Grant
- 2002-04-22 US US10/127,100 patent/US6512123B2/en not_active Expired - Fee Related
-
2003
- 2003-10-06 ZA ZA200307793A patent/ZA200307793B/en unknown
-
2007
- 2007-10-11 CR CR9430A patent/CR9430A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US6512123B2 (en) | 2003-01-28 |
KR100591501B1 (ko) | 2006-06-19 |
ATE306480T1 (de) | 2005-10-15 |
MXPA03009132A (es) | 2004-02-12 |
ZA200307793B (en) | 2005-01-06 |
DE60206616D1 (de) | 2006-02-23 |
CN1507441A (zh) | 2004-06-23 |
KR20030090771A (ko) | 2003-11-28 |
CR9430A (es) | 2008-04-25 |
JP4142453B2 (ja) | 2008-09-03 |
EP1385837A1 (en) | 2004-02-04 |
CA2442994A1 (en) | 2002-10-31 |
WO2002085883A1 (en) | 2002-10-31 |
AU2002254991B2 (en) | 2007-07-19 |
ES2249572T3 (es) | 2006-04-01 |
US20020183513A1 (en) | 2002-12-05 |
EP1385837B1 (en) | 2005-10-12 |
DE60206616T2 (de) | 2006-07-13 |
JP2005503341A (ja) | 2005-02-03 |
CN1310904C (zh) | 2007-04-18 |
AR035455A1 (es) | 2004-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0209064A (pt) | Hidroxamatos de alquila tricìclicos, sua preparaçãoe seu uso como inibidores de proliferação de células | |
BR0116402A (pt) | Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular | |
BR0307575A (pt) | Derivados de sulfonila como inibidores de histona desacetilase | |
BR0307606A (pt) | Derivados de piperazinila, piperidinila e morfolinila como inibidores de histona desacetilase | |
BR0308081A (pt) | Inibidores de histona desacetilase | |
BR0108678A (pt) | Novos compostos | |
BR0307607A (pt) | Derivados de carbonilamino como inibidores de histona desacetilase | |
BR0307599A (pt) | Derivados de sulfonilamino como inibidores de histona deacetilase | |
BRPI0414111A (pt) | inibidores heterocìclicos de mek e métodos de uso dos mesmos | |
BR0214666A (pt) | Derivados de acetileno tendo atividade antagonìstica de mglur5 | |
BR0111667A (pt) | Novos compostos | |
ECSP055671A (es) | Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa | |
EA200201271A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
BRPI0312464B8 (pt) | compostos inibidores de tirosina quinases, composições farmacêuticas compreendendo os mesmos, processos para fabricação e usos dos mesmos | |
NO20013220D0 (no) | Trombineinhibitorer | |
SE0301888D0 (sv) | New use VII | |
BRPI0515594A (pt) | inibidores da interação entre mdm2 e p53 | |
BRPI0419305B8 (pt) | compostos inibidores de p38, composições farmacêuticas compreendendo os mesmos e usos dos referidos compostos na preparação de medicamentos | |
BR0317348A (pt) | EnantiÈmeros de derivados de ácido tiofeno hidroxâmico e seu uso como inibidores de hdac | |
BRPI0413094A (pt) | derivados de quinolina e seu uso em terapia | |
SE9802206D0 (sv) | Novel compounds | |
BR0315820A (pt) | Inibidores de integrase de hiv, composições farmacêuticas e métodos para a sua utilização | |
SE0203070D0 (en) | Novel compounds | |
BR0211903A (pt) | Isoxazolopiridinonas | |
BRPI0416745A (pt) | novos compostos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 8A E 9A ANUIDADE(S) |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |